InvestorsHub Logo
Followers 7
Posts 798
Boards Moderated 1
Alias Born 08/30/2011

Re: None

Tuesday, 11/14/2017 8:49:48 AM

Tuesday, November 14, 2017 8:49:48 AM

Post# of 120
$SGBI - FDA GRANTS FAST TRACK DESIGNATION TO GRANULOX

FDA FAST Track Designation

FDA grants FAST TRACK DESIGNATION

Witten, November, 13, 2017: Infirst Healthcare Ltd has announced that the United States (US) Food and Drug Administration (FDA) has granted Fast Track designation to Granulox 10% haemoglobin spray (porcine haemoglobin) for the treatment of diabetic foot ulcers (DFUs). It is the first and only haemoglobin spray to receive Fast Track designation – a process designed by the FDA to facilitate the development, and expedite the review of, new therapies to treat serious conditions and fill an unmet medical need.

Wowsers! $$$ Big gainer this one! $$$ GLTA